The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126820861 12682086 1 I 20160815 20160824 20160824 EXP FR-FRESENIUS KABI-FK201605786 FRESENIUS KABI ROSSIGNOL J,TERRIOU L,ROBU D,WILLEKENS C,HIVERT B,PASCAL L. RADIOIMMUNOTHERAPY ((90) Y-IBRITUMOMAB TIUXETAN) FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AFTER PRIOR EXPOSURE TO RITUXIMAB. AM-J-TRANSPLANT 2015;15(7):1976-1981. 39.00 YR Y 0.00000 20160824 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126820861 12682086 1 PS CYTARABINE (Manufacturer Unknown) CYTARABINE 1 Unknown U UNKNOWN 76512 UNKNOWN
126820861 12682086 2 SS ETOPOSIDE. ETOPOSIDE 1 0
126820861 12682086 3 SS ZEVALIN IBRITUMOMAB TIUXETAN 1 0
126820861 12682086 4 SS CARMUSTINE CARMUSTINE 1 0
126820861 12682086 5 SS MELPHALAN MELPHALAN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126820861 12682086 1 Diffuse large B-cell lymphoma stage IV
126820861 12682086 2 Diffuse large B-cell lymphoma stage IV
126820861 12682086 3 Diffuse large B-cell lymphoma stage IV
126820861 12682086 4 Diffuse large B-cell lymphoma stage IV
126820861 12682086 5 Diffuse large B-cell lymphoma stage IV

Outcome of event

Event ID CASEID OUTC COD
126820861 12682086 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126820861 12682086 Febrile neutropenia
126820861 12682086 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found